Moderna stock hit a four-year high of $254.48 on Oct. 21. Today’s pullback will test the shares’ 30-day moving average, a trendline that buoyed yesterday’s selloff. Year to date, MRNA is still up 587% …
Moderna Stock Cools After Cancer Vaccine Data Leak
view original post